Correlation Between Genmab AS and Zealand Pharma
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Zealand Pharma AS, you can compare the effects of market volatilities on Genmab AS and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Zealand Pharma.
Diversification Opportunities for Genmab AS and Zealand Pharma
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Genmab and Zealand is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of Genmab AS i.e., Genmab AS and Zealand Pharma go up and down completely randomly.
Pair Corralation between Genmab AS and Zealand Pharma
Assuming the 90 days trading horizon Genmab AS is expected to generate 0.79 times more return on investment than Zealand Pharma. However, Genmab AS is 1.26 times less risky than Zealand Pharma. It trades about -0.06 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.55 per unit of risk. If you would invest 206,500 in Genmab AS on January 24, 2024 and sell it today you would lose (3,500) from holding Genmab AS or give up 1.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genmab AS vs. Zealand Pharma AS
Performance |
| Timeline |
| Genmab AS |
| Zealand Pharma AS |
Genmab AS and Zealand Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genmab AS and Zealand Pharma
The main advantage of trading using opposite Genmab AS and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.| Genmab AS vs. Ambu AS | Genmab AS vs. DSV Panalpina AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. GN Store Nord |
| Zealand Pharma vs. Ambu AS | Zealand Pharma vs. DSV Panalpina AS | Zealand Pharma vs. Bavarian Nordic | Zealand Pharma vs. GN Store Nord |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |